HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Bruker
Symbol: BRKR
Recent BRKR Price: $66.25
Average Analyst Price Target: $74.50 (12.45%)
BRKR Market Cap: $10.12B
Expected Ex-Dividend Date for BRKR stock: Nov 30 2022
Expected Payment Date for BRKR stock: Dec 16 2022
Expected Dividend & Yield for BRKR stock: 0.28%
Recent Analyst Action: Max Masucci, analyst at Cowen & Co., reiterates coverage on Bruker (BRKR) stock in the Healthcare sector with a Hold rating and a price target of $ 75 (2 weeks ago).
Click for full story on BRKR stock >>Recent Analyst Action: A.J. Rice, analyst at Credit Suisse, reiterates coverage on McKesson (MCK) stock in the Healthcare sector with a Buy rating and a price target of $ 419 (6 days ago).
Click for full story on MCK stock >>Recent Analyst Action: Anne Samuel, analyst at J.P. Morgan, reiterates coverage on Premier (PINC) stock in the Healthcare sector with a Hold rating and a price target of $ 30 (1 week ago).
Click for full story on PINC stock >>Recent Analyst Action: Jonathan Yong, analyst at Credit Suisse, reiterates coverage on Universal Health (UHS) stock in the Healthcare sector with a Buy rating and a price target of $ 157 (4 days ago).
Click for full story on UHS stock >>